USADA announced today that Devin Logan, of Park City, Utah, an athlete in the sport of freeski, has accepted a six-month suspension for an anti-doping rule violation.
Logan, 26, tested positive for 11-nor-9-carboxy-tetrahydrocannabinol (Carboxy-THC), a urinary metabolite of Δ9-tetrahydrocannabinol (THC), the main psychoactive constituent of cannabis, marijuana and/or hashish, above the urinary Decision Limit of 180 ng/mL, as the result of a urine sample collected in-competition at the Copper Grand Prix on December 7, 2018. Cannabis, marijuana and hashish are Specified Substances in the class of Cannabinoids and are prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the International Ski Federation Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
Logan accepted a six-month period of ineligibility that began on December 7, 2018, the date her positive sample was collected. Based on Logan’s successful completion of a USADA anti-doping educational tutorial, her period of ineligibility was reduced by three months. In addition, Logan has been disqualified from competitive results obtained on and subsequent to December 7, 2018, including forfeiture of any medals, points and prizes.
Athletes are advised that all natural and synthetic cannabinoids, except cannabidiol (CBD), are prohibited in-competition. Many products which claim to be pure CBD extract or oil from the cannabis plant have traces of THC or other cannabinoids. Thus, a consumer who buys a CBD oil, extract, or other CBD product should be aware that there is a high likelihood it is a mixture of CBD and other prohibited cannabinoids, such as THC. Therefore, the use of a CBD product that claims to contain trace amounts of THC, may in fact contain higher THC concentrations, which may result in an anti-doping rule violation if carboxy-THC is present in an athlete’s urine over the Decision Limit in a sample collected in-competition. USADA cannot predict the levels for any substance for any particular individual. In addition, consumers should also be aware of recent changes to federal law and FDA regulations on cannabis and cannabis-derived products to protect themselves from illegal products and therapeutic claims.
If an athlete needs to therapeutically use a substance prohibited in-competition and they are nearing a competition, they are strongly encouraged to contact USADA to learn if they need a Therapeutic Use Exemption (TUE).
In an effort to aid athletes, as well as support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements (www.Supplement411.org) as well as performance-enhancing and recreational drugs. In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as an easy-reference wallet card with examples of prohibited and permitted substances, a supplement guide, a nutrition guide, an athlete handbook, and periodic alerts and advisories.
Along with education and testing, robust anti-doping programs enable investigations stemming from tips and whistleblowers. USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at playclean@usada.org, by phone at 1-877-Play Clean (1-877-752-9253) or by mail.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.